Niederhauser, Andrea; Brühwiler, Lea D; Fishman, Liat; Schwappach, David LB (2019). [Selected safety-relevant medication processes in Swiss nursing homes: Current state of affairs and optimization potentials]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 146, pp. 7-14. Elsevier, Urban & Fischer 10.1016/j.zefq.2019.06.005
|
Text
Niederhauser ZEvidFortbildQualGesundhwes 2019.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (607kB) | Preview |
BACKGROUND
Reducing adverse drug events in nursing homes is a central patient safety concern. The aim of this study was to assess how often selected medication processes to increase medication safety are already implemented in Swiss nursing homes and to examine how nursing homes that have not yet implemented these processes can be characterized based on their organizational features.
METHODS
Cross-sectional survey study among directors of nursing in Swiss nursing homes.
RESULTS
420 of 1,525 invited individuals participated in the survey (response rate: 27.5 %). Of these, 65.0 % stated that regular systematic medication reviews have been provided in their institution. 9.5 % of the nursing homes use a list to identify potentially inappropriate medication, and 6.7 % of the nursing homes have a standardized process to monitor side effects of medications. 66.0 % of the participating nursing homes have implemented at least one of these three processes, 34.0 % of the participating nursing homes have not implemented any of the three processes. Statistically significant differences in process implementation were found according to the geographical location of the nursing home, the type of documentation used for medications, the physician model, the number of external general practitioners, as well as the medication supply channel and the legal obligation to cooperate with pharmacists. No differences were found with regard to the nursing home size.
CONCLUSION
In Swiss nursing homes, central safety-relevant medication processes have not yet been implemented nationwide. In particular, implementation is not widespread in nursing homes where medical care for their residents is provided by many different external general practitioners. The organizational features need to be taken into account to successfully implement quality improvement measures.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM) |
UniBE Contributor: |
Schwappach, David |
Subjects: |
600 Technology > 610 Medicine & health 300 Social sciences, sociology & anthropology > 360 Social problems & social services |
ISSN: |
1865-9217 |
Publisher: |
Elsevier, Urban & Fischer |
Language: |
German |
Submitter: |
Doris Kopp Heim |
Date Deposited: |
15 Aug 2019 16:41 |
Last Modified: |
05 Dec 2022 15:30 |
Publisher DOI: |
10.1016/j.zefq.2019.06.005 |
PubMed ID: |
31375396 |
Uncontrolled Keywords: |
Alters- und Pflegeheime Patientensicherheit Polymedikation Potenziell inadäquate Medikamente Langzeitpflege long-term care nursing homes patient safety polypharmacy potentially inappropriate medication list |
BORIS DOI: |
10.7892/boris.132630 |
URI: |
https://boris.unibe.ch/id/eprint/132630 |
Actions (login required)
 |
Edit item |